Expertise in peptide analysis, biomarker studies and Mass Spectrometry analysis
Well respected within the industry for his ground-breaking work in peptide and biomarker studies, Andrew holds over 15 years industry experience, including two years as Consultant for BioInnovation SA.
Highly experienced in managing bio-analytical facilities, and an expert in developing bio-analytical methods using tandem mass spectrometry, Andrew has extensive experience ensuring compliance with quality systems such as GLP and ISO 17025.
With a reputation for rescuing seemingly impossible clinical trials, Andrew was responsible for successfully leading the CPR laboratory through an FDA inspection.
A key member of the CPR Management team and a regular attendee at international conferences and events, Andrew is committed to remaining at the forefront of bio-analytical science.